share_log

Argenica Therapeutics Ltd: FDA Grants ODD & RPDD for Second Drug in Treatment of HIE

ASX ·  Oct 30, 2024 09:25
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more